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httpThe best vascular care for every patient, every day
Peter Gloviczki, MD, Rochester, MinnIt has been a singular honor and a privilege to serve as
the 67th president of this distinguished society. A true
American dream, when someone born behind the Iron
Curtain, raised in communist Hungary, immigrates to
this great nation, joins the staff of Mayo Clinic, and com-
pletes his term as president of the most prestigious vascular
surgical society in the world. It is humbling to look around
the room and see hundreds of colleagues I admire,
including past presidents, giants of our profession who
guided us during the past decades so that today we have
a society that is stronger, larger, and more vibrant than
any time before. I am thankful to them for their vision
and hard work. I am equally thankful to the current leader-
ship of the Society for Vascular Surgery (SVS), to a dedi-
cated staff and hundreds of volunteers, many here today,
who helped me build a better society and strengthen our
profession during this past year.
Presidential addresses have dealt with many issues in
the past, with our quest for excellence,1 with Charles Dar-
win and vascular surgery,2 with education,3 research,4 and
the state of a successful union of two societies,5 the SVS
and the American Association for Vascular Surgery
(AAVS), which took place exactly 10 years ago. We were
also told that results mean everything6 and that to survive
we must change, adopt, retrain, innovate and, at any price,
remain leaders in the vascular ﬁeld.7-11 Last year, president
Richard Cambria’s presentation was about the endovascu-
lar revolution and the current state of carotid endarterec-
tomy and stenting, two of the many important
interventions we perform.12
The topic I selected has been close to my heart all my
life and affects each of us. It is about the very essence of
why we became physicians and surgeons, why we wentthe Division of Vascular and Endovascular Surgery, Mayo Clinic.
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and continued with further education to become vascular
surgeons. Today, I would like to talk to you about our
continuing mission to deliver the best vascular care to every
patient, every day.
To achieve this noble goal has never been easy. Today,
in this country, we are faced with changes in health cared
likely more than at any time before. Vascular surgeons and
our society need to understand and meet new challenges.
We must be leaders and active participants in making and
inﬂuencing important decisions affecting our patients, our-
selves, our profession, and vascular health care. We need to
progress and innovate, and we need funding for research
and to receive fair compensation for the work we do, but
we also need to stay focused on our patients without ever
compromising our basic principles.
My message to you is simple and applies to all of us
who participate in the care of patients with vascular disease.
I am asking you to remember what one of the Mayo
brothers, Dr William J. Mayo (Fig 1) said, that the best in-
terest of the patient is the only interest to be considered.13
This is essential because we took our oath and signed up to
be in this profession for one ultimate goal: to deliver the
best vascular care to our patients.
You will understand better why I feel this is so impor-
tant if you allow me to reveal some details of my personal
life. I would like to tell you about those who inspired me
and thank those who helped me to get where I am today.
I will review some of the changes in health care and share
with you my thoughts on how to meet the challenge: on a
personal level, as a vascular surgeon, and with the help of
an exceptional society, the SVS. Finally, I would like to
share with you my thoughts of what our specialty, vascular
surgery, needs to accomplish to survive, to prosper, and to
lead vascular care in this country and in the world.
PERSONAL REFLECTIONS
You heard many details of my life from Dr Julie
A. Freischlag, and you probably imagine that it was not
very simple for me to get from Hungary to Rochester,
Minnesota, where I have lived and practiced for the past
32 years.
The Physician. My life’s journey reminds me some-
what of the epic adventures of Rob Cole, hero of Noah
Gordon’s brilliant historical ﬁction novel, The Physician.14
Rob Cole, a 9-year-old boy, who feels called to be a843
Fig 1. Drs William J. Mayo and Charles H. Mayo, circa 1910.
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to a traveling barber-surgeon. He acquires basic healing
skills, but to make a living, he also has to learn how to
juggle, entertain the crowd, and perform magic tricks.
Against all odds, Rob stays true to his mission to
become a physician. He travels through Europe to Jerusa-
lem and then all the way to Ispahan, Persia, where he at-
tends medical school and learns from the greatest
physician of his time, Avicenna. This adventurous and
inspiring tale of a quest for medical knowledge is ﬁlled
with fascinating details of the medieval medical education
and practice and of the life of physicians with three reli-
gions, Islam, Judaism, and Christianity.
Early years. The journey I travelled was deﬁnitely less
dangerous than that of Rob Cole, but to me, it was equally
exciting and certainly eventful. I started out in Eastern
Europe, in Hungary. I was born in the northeastern city
of Nyiregyhaza, where my father Zoltán and my mother
Eva lived with their ﬁve children (Fig 2). I was 6 years
old when someone asked me what I wanted to be when
I grew up. I said “professor of surgery.” Coming from a
6-year-old, the directness of the answer was surprising, but
to me, the decision was easy. I come from a family of
doctors: my father, grandfather, one brother, and an uncle
were all physicians.
My greatest inspiration came from my father: to me, he
was the best and most compassionate physician I have ever
known. My sister, who is here today from Hungary, knows
that our father and our beautiful and loving mother
both had great inﬂuence on us: they taught us love, hardwork, honesty, and integrity. From my father, I also
learned the love of medicine, love of the patient, how to
strive for perfection, and why we should respect our med-
ical colleagues. He showed me the example to continu-
ously update our medical knowledge. I remember well at
the end of long days and after seeing dozens of patients,
he was regularly reading the Hungarian Medical Journal.
Even when I became a consultant at Mayo Clinic, he
sent me articles that he snipped from his journal and under-
lined sentences that he thought were important. For the
love and support I received from my parents, I will always
be very thankful.
Boarding school. I will never forget the next stop in
my journey at a boarding school in western Hungary,
where I spent 4 years of my life. The school was the Bene-
dictine High School of the Archabbey of Pannonhalma
(Fig 3).15 This historical monument was founded in 996
on the mountain of St. Martin and it is also a UNESCO
(United Nations Educational, Scientiﬁc and Cultural Or-
ganization) World Heritage site.15
For a time, I wanted to be a monk, but this did not last
longer than a week, and during the rest of the 4 years of my
attendance, I reinforced my plan to become a physician. I
took classes to prepare for medical school, and I learned
English, German, Russian, and Latin.
Semmelweiss Medical School. My next stop was
Budapest, where I attended medical school. Founded in
1769, the school later took the name of the 19th century
Hungarian physician Dr Ignaz Philipp Semmelweis
(Fig 4), pioneer of antisepsis and also called the savior of
mothers.16 As early as 1847, Semmelweis introduced hand
washing with bleach and drastically decreased death from
puerperal fever in the Vienna General Hospital, in Austria,
from 18% to <1%.
My ﬁrst surgical mentor in Budapest was one of the
ﬁrst Hungarian vascular surgeons, Professor Lajos Soltesz.
He was a great humanist, a patient’s advocate, and an
inspiring teacher who taught me the tenants I have fol-
lowed in my life; that vascular surgeons should take care
of the full spectrum of vascular diseases, including arterial,
venous, and lymphatic problems.
Paris, France. Professor Soltesz sent me to Paris to
spend time with Drs Jean-Michel Cormier and Marceau
Servelle to learn the French techniques of vascular surgery,
the treatment of venous diseases and lymphedema, and
lymphatic microsurgery. The year I spent in France, the
country that contributed so much to vascular surgery, was
exciting, inspirational, and enlightening. The words that
changed my life came from Servelle: “Monsieur Peter,” he
said, “the best place in the world for medicine is Mayo
Clinic.” That was all I needed to know. If the best place in
the world is Mayo Clinic, then that is where I have to go.
Rochester, Minnesota. It took me 6 more years, but
in June 1981, I ﬁnally arrived in Rochester, Minnesota. I
owe a lot to Dr Larry H. Hollier, a great surgeon and dy-
namic leader, ﬁrst head of the Section of Vascular Surgery
at Mayo Clinic. With the help of Dr Alexander Schirger, an
exceptional Mayo Clinic physician, and with funds from the
Fig 2. The Gloviczki family in Hungary, circa 1958 (the author in the middle).
Fig 3. The Benedictine Archabbey and High School of Pan-
nonhalma, Hungary.
Fig 4. Hungarian physician and pioneer of antisepsis, Dr Ignaz
Philipp Semmelweiss (1818-1865). Painting of Mór Than,
circa 1884.
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fellow. I spent a year and a half in research and then
completed a clinical vascular surgery fellowship. To meet
the requirements of the American Board of Surgery, I
needed to repeat most of the general surgery residency I
completed previously in Europe.
After 15 years of wonderful surgical training, the
impossible dream came true: I got a position on the staff
and became a Mayo Clinic surgeon. On my road to accom-
plish this, three great mentors helped me: Drs Peter C.
Pairolero, Kenneth J. Cherry, and John W. Hallett, who
later became my colleagues and friends (Fig 5).
I have been blessed that during the past 25 years, I had
the opportunity to work with the very best colleagues and
skillful surgeons one can have, and I am thankful for their
help, expertise, and friendship. I am also grateful for the
opportunity to contribute to the education of 74 bright
vascular surgery fellows (Fig 6), and I appreciate that so
many of them traveled to San Francisco to attend thismeeting. You are the ambassadors of vascular surgery at
Mayo Clinic, and you represent 2.6% of this country’s prac-
ticing fellowship-trained vascular surgeons. Now more than
any time before, I understand what Dr William J. Mayo
said in 1931 that, “each day as I go through the hospitals
surrounded by younger men [and I would add today:
women], they give me of their dreams and I give them
Fig 5. The Section of Vascular Surgery at Mayo Clinic in 1987
(from left: Drs Larry H. Hollier, Kenneth J. Cherry, Peter Glo-
viczki, John W. Hallett, and Peter C. Pairolero).
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have been equally inspired by medical students and
research fellows, many coming to learn at Mayo Clinic
from far away countries (Fig 7). Finally, I would like to
thank again the current dedicated staff of our division
(Fig 8) that works so hard to provide the best vascular
care to every patient, every day.
I have been impressed and inspired by the work ethic,
expertise, and dedication of three people, all here today,
who have helped me during so many years at Mayo Clinic:
my scrub nurse of 24 years, Donella Rossi, CST; our
Administrative Assistant of 24 years, Marcia Simonson;
and my Physician Extender during the past 20 years, Linda
Canton, RN, BSN, CVN. Because of them, I feel every day
that my team is the dream team.
My family. I would be remiss if I did not tell you how
much I appreciate of having a remarkable and loving fam-
ily. My son Peter is a fresh doctor of philosophy and a
proud poet who recently published his ﬁrst collection of
poems. My daughter, Julia, completed her studies in veter-
inary medicine in the spring of 2013. She is also a compet-
itive horseback rider. Ben, my son-in-law, is ﬁnishing his
PhD in mathematics at UC Davis, and Michael, my step-
son, is a professional artist and painter who lives in Paris,
France. There is never a dull moment in this family. Still my
biggest gift, coming from Paris is my wonderful wife,
Monika. She tries to keep balance and peace in the family
and gives me love and friendship I have never known
before. She is also my coauthor, coeditor, and a perfect
travel companion. Monika, thank you for everything,
including your generous support of my professional life and
your unbelievable patience during the busy year of my SVS
presidency.
Mayo Clinic. Because I spent most of my adult life in
Rochester, Minnesota, I would like to say a few words aboutmy workplace (Fig 9). Mayo Clinic, founded at the turn of
the last century by the Mayo family, is the ﬁrst and the
largest group practice in the United States. It builds on
teamwork and collaboration among specialties to provide
the best care to the patients and is joined by common sys-
tems and the philosophy that the needs of the patients come
ﬁrst. The clinic has grown and spread to Florida and
Arizona, and each place has strong vascular surgery services.
In Rochester, vascular disease is treated in the multidis-
ciplinary Gonda Vascular Center. This center was made
possible because of the vision and generous philanthropy
of the Hungarian-born Leslie Gonda, son Louis Gonda,
and their families. Their support of vascular care in this
country has been exemplary: the Gonda’s also sponsored
a vascular center at the University of California in Los
Angeles.
Working with colleagues of other vascular specialties in
a team can certainly be a challenge, but it is also a source of
inspiration and transparence. I suspect we will see this
model in large institutions more frequently in the future,
and we must be certain that vascular surgeons are involved
and lead. Just keep in mind: your success does not depend
on failures of others. Working together enables us to
develop programs that cover the full spectrum of vascular
diseases: arterial, venous, and lymphatic. The focus in the
Mayo Clinic model of care is on a high quality and compas-
sionate patient care. The practice is multidisciplinary and
integrated, and the three shields of the Mayo Clinic repre-
sent clinical practice, education, and research.
Dr Oliver H. Beahrs. I have had many role models at
Mayo Clinic, but the person who inspired me most was Dr
Oliver H. Beahrs, a wonderful man and one of the most
dexterous surgeons the clinic has ever known. He achieved
everything a surgeon can dream of, including presidency of
the American College of Surgeons (Fig 10, A). He
described his dedication to Mayo and to American surgery
in his personal memoirs18 and included stories of his
colorful life, from being a navy pilot during World War II
to his magic performances on cruise ships in Alaska: so here
we are, we shared a common interest in magic.
I am so proud that we have been the only two at Mayo
Clinic to have a door card related to magic. I remember
fondly when we performed a magic show together at the
banquet of the Minnesota Surgical Society, but the real
honor that I cherish dearly came later when I received
the title of his named professorship. President Ronald Rea-
gan, Dr Beahrs’ patient and friend, wrote for his retire-
ment: “over the last four decades through your work
with Mayo Clinic, you have touched the lives of countless
many. Your efforts reﬂect the generous spirit of self-
sacriﬁce and service to others that is the real source of
America’s strength” (Fig 10, B). Dr Beahrs was indeed
the epitome of the American spirit of service and self-
sacriﬁce, something that we have witnessed so well in our
surgeons, emergency department physicians, nurses, and
teachers during the recent catastrophes at the Boston
Marathon in Massachusetts and in the devastation caused
by the tornado in Moore, Oklahoma.
Fig 6. Vascular surgery fellows at Mayo Clinic, Rochester, Minnesota (1987-2013).
Fig 7. Medical students and international research fellows in vascular surgery at Mayo Clinic, Rochester, Minnesota
(1982-2013).
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him would react to the recent major changes in our health
care. Although Mayo Clinic was always ready for a change,
and as early as 1931, Dr Charles Mayo said, “Today the
only thing that is permanent is change,”19 I doubt however
that Dr Mayo had the Affordable Care Act in mind.
CHANGES IN HEALTH CARE
John H. Noseworthy, MD, Chief Executive Ofﬁcer
(CEO) and President of Mayo Clinic, told us that Mayois facing challenges unlike any we have experienced
before.20 Gary Gottlieb, MD, President and CEO of Part-
ners Health Care, Boston, Massachusetts, commented “.
there is substantial pressure to move rapidly towards
improvement of public health and reduced spending of
complex care.”21 Sean Leyden, MD, from Cleveland
Clinic, wrote that their CEO, Dr Delos Cosgrove, made
them question how they spend money, how they get pa-
tients more efﬁciently through the system, and how they
try to keep patients out of the hospital.22
Fig 8. The Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, Minneosta, in 2013.
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extent by the increasing costs of health care in the United
States vs other countries in the world.23 The pressure to
change further increased when a World Health Organiza-
tion (WHO) report in 2000 ranked health care in the
United States 37th in the world, placing our country
somewhere between Costa Rica and Slovenia.24 This low
total score was assigned despite ranking ﬁrst in the only
category that really counted, “responsiveness to the needs
of the patient.” In categories such as “ﬁnancial fairness,”
countries with government-paid care ranked high, even if
the care the patients received was poor.23 Just 1 month af-
ter the Affordable Care Act was approved, Dr Philip Mus-
grove wrote in a letter to the New England Journal of
Medicine, “There are sound reasons to mistrust the con-
ceptual framework behind the estimates. And that it is
long past time for this zombie number to disappear from
circulation.”25 This was a peculiar and quite late statement
coming from the editor of the very same WHO report that
spoke up so harshly about the health care in this country.
Health experts like Betsy McCaughey23 also call atten-
tion to data that prove that money for research in this
country was well spent: in the past 113 years, scientists
from the United States have won more Nobel prizes in
physiology and medicine than the rest of the world com-
bined (Fig 11).23,26,27
But new health care is now and is here to stay, with
noble goals to reduce health care costs, to increase the
rate of health insurance coverage, and to decrease insurance
premiums. Instead of fee-for-service that has been a
volume-based reimbursement, providers will receive global
payments for taking care of people over time (value-basedreimbursement). The goal is to improve outcomes and
streamline delivery of health care.
Vascular surgeons and the Affordable Care Act. So
how are vascular surgeons affected in the Affordable Care
Act? We will pay more taxes, and we will also pay a penalty
after 2015 if we do not participate in the Physician Quality
Reporting System (PQRS). Codes will be re-evaluated,
payment for multiple procedures will decrease, and the
Independent Payment Advisory Board will have the rights
to cut payment to vascular surgeons. Earlier this year, a 2%
cut for Medicare patients was enacted.
The focus will be on primary care. The idea is that
enhancing preventive care will eventually decrease health
care costs. Funding will be shifted from specialists to pri-
mary care, and this will affect training and reimbursements
of vascular surgeons.
MEETING THE CHALLENGE
Several solutions are available that will help us in
meeting this challenge. We need to participate in an
approved clinical data registry, such as the SVS Vascular
Quality Initiative (VQI). We need to use electronic health
records and electronic prescriptions, report radiation expo-
sure times, report the methods we use to calculate carotid
artery stenosis, and our surveillance after endovascular
repair of aortic aneurysms. We can use any of the other
already approved measures as well.
Voice your concern, just as Dr Frank J. Veith did in a
recent issue of the Vascular Specialist, where he made a
point that “primary care physicians don’t get patients
well.”28 Referring to vascular surgeons, Dr Veith said
that, “These skilled specialists have to work hard and
Fig 9. The Gonda Building of the Mayo Clinic, Rochester, Minnesota.
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available 24/7 to provide emergency treatment when mi-
nutes and hours make a difference., they deserve to be
highly compensated in keeping with other professions
that have similar requirements.”
After discussing this with our SVS health policy experts,
Drs Robert M. Zwolak and Sean P. Roddy, we came up
with a number of suggestions on how vascular surgeons
could succeed in the Affordable Care Act. Needless to
say, we need to maintain and develop the widest possible
expertise in open surgical and endovascular procedures,
including access, amputations, spine exposures, and in
all aspects of a vascular laboratory. This will make usindispensable. We should never forget how to perform
the highest-quality open vascular surgery, because no one
else can do it. We need to focus on treating the disease.
If that means learning to inject stem cells or perform embo-
lization, endothermal venous ablations, or sclerotherapy, so
be it.
Vascular surgeons should also be familiar with values in
health care and remember the equation: value means qual-
ity, safety, and service divided by cost. It will be more and
more difﬁcult to justify procedures that are not cost-
effective. Our advice to you is that you learn how to be
team players and leaders in big medical center environ-
ments. Retain recognition as honest brokers at national
Fig 10. A,Dr Oliver H. Beahrs (1914-2006), Mayo Clinic surgeon and 1988-1989 President of the American College
of Surgeons. B, Letter of President Ronald Reagan to Dr Oliver H. Beahrs, written on April 28, 1993.
Fig 11. Nobel Prizes in Physiology and Medicine (1901-2013) based on afﬁliation at the time of award or country
where research conducted. Two countries were named for six of 204 awardees.
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seek and train people who want to do great work by being
a great doctor and earning a good wage and not just a
good doctor earning a great wage. As Steve Jobs once
shared, your work is not for money and “your work is
going to ﬁll a large part of your life, and the only way to
be truly satisﬁed is to do what you believe is greatwork. And, the only way to do great work is to love
what you do.”29
THE SOCIETY FOR VASCULAR SURGERY
Our society is a society for vascular surgery, so what can
SVS do to meet the challenge? Let me tell you ﬁrst what
many of you already know, that SVS is an organization
Fig 12. A, Hungarian born Dr Geza de Takats (1892-1985), one of the founders and the seventh president of the
Society for Vascular Surgery (SVS). B, Vascular Surgery, one of the ﬁrst vascular surgery textbooks from the United
States, written by Geza de Takats (W. B. Saunders, Philadelphia; 1959).
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Historically, we are connected to our host city of San Fran-
cisco, where on July 3, 1946, nine visionary surgeons, Drs
Michael E. DeBakey, Daniel C. Elkin, Norman E.
Freeman, Emile Holman, John Homans, Robert R. Lin-
ton, Alton Ochsner Sr, Geza de Takats, and J. Ross Veal
founded SVS. The ﬁrst meeting the following year was
organized in Atlantic City. Of the founding fathers, the
gentleman who inspired me most was Dr Geza de Takats.
Dr Geza de Takats. Geza de Takats (Fig 12, A) was
born in Budapest, Hungary, on December 9, 1892, where
he went to medical school and completed his surgical res-
idency. He immigrated to the United States and ﬁrst
worked at Mayo Clinic in Rochester, Minnesota, as a
traveling fellow of the Rockefeller Foundation. In 1925, he
settled in Chicago and worked as a surgical fellow under Dr
Allan B. Kanavel. He later became the head of the vascular
clinics at Northwestern University and then at the Uni-
versity of Illinois.
His interest in vascular diseases was broad and included
aneurysms and vascular grafts, venous disease, varicose
veins, thrombosis, ﬁbrinolysis, sympathectomy, and lym-
phedema.30 He wrote one of the ﬁrst textbooks on vascular
surgery (Fig 12, B).31 I received a copy of his book from
my partner and good friend Dr Kenneth Cherry, who
noted in his dedication that “. there must be something
to be a Hungarian and a great and pioneering vascular sur-
geon.” Dr Cherry obviously referred to Dr Geza de Takats,
who became the seventh president of the SVS 60 years
ago.32 But he was also thinking of another great Hungarian
vascular surgeon, Dr D. Emerick Szilagyi (Fig 13), who30 years ago, right here in San Francisco, was the 37th
president of our society.32
Dr D. Emerick Szilagyi. Born on June 20, 1910, in
Transylvania, territory of Austria-Hungary, D. Emerick
Szilagyi (1910-2009) started medical school at the Sor-
bonne in Paris, France.33 He continued his medical studies
in Debrecen, Hungary, at the same medical school where
my father, Zoltán, started his studies just a few years later.
He immigrated to the United States and then graduated
from the University of Michigan in 1935. Szilagyi
completed his surgical residency at Henry Ford Hospital in
Detroit and became a member of and, in 1966, Chairman
of the Department of Surgery.
Dr Szilagyi was Editor-In-Chief of the Journal of
Vascular Surgery and 37th president of the SVS. He wrote
seminal papers on aortic aneurysms, homografts, prosthetic
grafts, and vein grafts, and made important contributions
to the literature on arteriovenous malformations.34-36 His
presidential addresses discussed the role and importance
of the art of medicine, the historical development and
challenges of physician-patient relationships, and the signiﬁ-
cance of truth in scientiﬁc reporting.37-39 Art, compassion,
surgical skills, leadership, wisdom, and integrity: these terms
summarize the legacyofDrD.EmerickSzilagyi. Shortly after
completinghismemoirs,33 he passed away in2009, at age99.
The new SVS. A transforming event in the life of the
SVS occurred 10 years ago when the society united with
the AAVS. A new society was born that kept the name of
SVS. The merger, which was documented in great detail
by Dr Jack L. Cronenwett,5 turned out to be the best
move the society has ever made. Ten years later, we are
Fig 14. Financial trends of the Society for Vascular Surgery (SVS)
between 2004 and 2012, including total assets and annual
income.
Fig 15. Trends in Society for Vascular Surgery (SVS) membership
numbers between 2004 and 2013, including total numbers and
international membership.
Fig 13. Cover of the memoirs of Hungarian born Dr D. Emerick
Szilagyi, 37th president of the Society for Vascular Surgery (SVS)
and former editor-in-chief of the Journal of Vascular Surgery. (Oil
portrait done by his wife Eve, 1963). Published by Greenwood
Academic, Evanston, 2008.
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(Fig 14.). Our membership has doubled in 10 years
(Fig 15). If this year’s candidates are approved at our
business meeting, the growth will be 110%, with a large
increase in our international memberships: we now have
eight international chapters. Our new ofﬁce in Chicago
started out with three administrators in 2003, we had seven
people there in 2007, and today, our two ofﬁces in Chi-
cago and Washington, D.C., have a professional staff of 22
members. The SVS governance has also grown, the board
works with ﬁve councils and 33 committees or work groups
to serve our constituents. I am grateful to have worked
with an extraordinary group of dedicated surgeons and staff
and appreciated very much the superb leadership of our
executive director, Rebecca Maron. Read the SVS annual
report to learn what this society is doing for you, because in
this address, I will only hit some of the highlights.
SVS activities in 2012-2013
Patient Safety Organization. The SVS Patient Safety
Organization (PSO) was approved last year. It is now listedamong 75 PSOs by the Agency for Healthcare Research
and Quality (AHRQ) and was cited at its annual meeting
as a leader in quality improvement. The program has
grown by leaps and bounds. We collect data from 228 cen-
ters in 45 states and Ontario, Canada. We have 15 regional
groups and several more are in the pipeline. Data on almost
90,000 procedures have already been collected, and each
month, >4000 new cases are added. We extended VQI
to venous disease, and with representatives from the Amer-
ican Venous Forum, we established a Venous Quality
Committee. In February, we released the inferior vena
cava ﬁlter module, and additional modules are in prepara-
tion and will be introduced soon.
Issues in venous disease. We all can be very proud of
the new journal started in January 2013 in collaboration
with the American Venous Forum, the Journal of
Vascular Surgery: Venous and Lymphatic Disorders.
Another initiative took place in February when the SVS
and the Society for Interventional Radiology formed a
Table. Goals of the new strategic plan of the Society for
Vascular Surgery (SVS)a
No. Major area Strategic goals
1. Vascular care The SVS will deﬁne and promote evidence-
based, high-quality, cost-effective vascular
care to improve patient outcomes
2. Education The SVS will adopt innovative educational
methodologies to ensure high-quality
vascular surgeons now and for the future
3. Advocacy The SVS will advocate on behalf of vascular
patients and vascular surgeons with key
policymakers, both public and private
4. Branding The SVS will enhance the public’s
understanding of the unique capabilities of
vascular surgeons
5. Discovery The SVS will foster research and innovation
with scientiﬁc integrity to optimize
vascular health
6. Sustainability The SVS will operate in sustainable,
transparent, and inclusive ways that serve
members with high-quality and relevant
initiatives
aApproved by the SVS Board of Directors on May 29, 2013.
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the Safety and Effectiveness of Inferior Vena Cava Filters
(PRESERVE) study, the ﬁrst large-scale North American
multispecialty prospective study to evaluate the use of
inferior vena cava ﬁlters.
Outcome Committee. The SVS Outcome Committee
succeeded in bringing together all stakeholders for the post-
approval assessment of thoracic endografts used for treat-
ment of acute, complicated, type B aortic dissection. Dr
Rodney A. White, Dorothy B. Abel, and others published
key papers earlier this year to answer the question why an
investigator-sponsored investigational device exemption is
required to conduct Food and Drug Administration-
approved clinical studies of signiﬁcant risk devices.40,41
Clinical Practice Council. Our Clinical Practice
Council, chaired by Dr Ruth Bush, has worked with several
committees. To assist our private practice physicians, the
Community Practice Committee, under the leadership of
Dr Richard A. Lynn, presented valuable documents on
compensation plans and practice mergers at the SVS Web
site (vascularweb.org).42 The SVS Women Leadership
Committee, chaired by Dr Eva M. Rzucidlo, is concerned
with women’s health, and in April 2013, published a
Journal of Vascular Surgery supplement on this topic. Di-
versity and inclusion have become core values of our so-
ciety in our new strategic plan.
Educational Council. The SVS is proud of the
numerous educational activities overseen by our Education
Council under the leadership of Dr Cynthia E. Shortell.
These include the Vascular Annual Meeting, organized
with Program Chair Dr Ronald M. Fairman, our postgrad-
uate courses (Chair: Dr Jon Matsumura), the SVS/Society
of Thoracic Surgeons/American Association for Thoracic
Surgery Symposium (Chairs: Drs Roy K. Greenberg and
Lars Swenson), the Vascular Review Course (Drs Cynthia
E. Shortell and William D. Jordan), the Coding and Reim-
bursement Courses (Chair: Dr Sean P. Roddy), and the
Vascular Research Initiative Conference (Chair: Dr Alan
Dardik). We are working on our Continuing Medical Ed-
ucation tracking system, Vascular Education and Self-
Assessment Program (VESAP) 1 and 2 have been most
successful, and VESAP 3 is in full preparation by Drs Kim J.
Hodgson and John F. Eidt, just as is the 8th Edition of
Rutherford’s Vascular Surgery, expertly edited by Drs Jack
L. Cronenwett and K. Wayne Johnston.
Research Council. Our Research Council, chaired
by Dr Larry W. Kraiss, published on our Vascular Research
Initiative conferences and on high-impact clinical research
priorities of the SVS.43,44 This year, we supported the
Society for Vascular Nursing Carotid Guidelines and the
American College of Cardiology Guidelines on Venous
Ultrasound and Physiologic Testing. The SVS Document
Oversight Committee, chaired by Dr Wayne Johnston, just
approved the Adverse Events Reporting Standards (Part
1). Close to completion are the multidisciplinary Ulcer
Guidelines and the ﬁrst part of our Peripheral Arterial
Disease (PAD) Guidelines. Many more projects are in
preparation.Health Policy Committee. In the era of new health
care, our Health Policy Committee has taken on an
increasingly important role. The charge of this committee
is to determine SVS positions on legislative and regulatory
issues with impact on vascular surgeons and their patients.
They monitor and participate in advocacy efforts for Medi-
care physician payment reform, removal of the Sustainable
Growth Rate formula, and creation of payment reform rec-
ommendations for vascular surgery. They also monitor and
participate in removing barriers to abdominal aortic aneu-
rysm screening, averting additional cuts to vascular ultra-
sound screening, repealing the Independent Payment
Advisory Board, and supporting comprehensive medical li-
ability reform.
I am proud to say that the SVS Board approved a
Medicare Physician Payment Plan, which has been pre-
sented to members of the House Energy and Commerce
and of the Ways and Means Committees. Dr Sean P.
Roddy’s presentation was well received this April at the
Surgical Coalition Meeting in Washington, D.C.
New strategic plan. After a successful retreat in
January by the SVS leadership, a new strategic plan was
presented to the board by President-Elect Dr Julie A.
Freischlag. The plan, approved just 2 days ago, contains
six major strategic goals for our society to accomplish
(Table).
THE SPECIALTY OF VASCULAR SURGERY
Let me share with you my thoughts on how the spe-
cialty of vascular surgery will meet the challenge of the
next 5 to 10 years. Dr Valentine and colleagues45 recently
reported the evolving patterns of vascular surgery in the
United States. Case logs of surgeons seeking recertiﬁca-
tions from 2007 to 2009 were reviewed and major vascular
Fig 16. Distribution of peripheral vascular stent procedures
(Current Procedural Terminology code 37205) by specialties ac-
cording to Medicare claims. Vascular surgery includes general
surgery, and radiology includes interventional radiology. (Redrawn
from data of Contos B. 2013 and beyond: the outlook for endo-
vascular services. Endovasc Today 2013:28-40.)
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General surgeons perform an average of 10 major vascular
cases compared with 192 by vascular surgeons. This differ-
ence was even more striking when endovascular cases were
counted. Because the evidence is overwhelming that most
general surgeons no longer do major vascular cases, we
need to grow as a specialty to meet future needs.
Vascular surgery training. Fortunately, vascular sur-
gery training programs in North America are excellent.
Our specialty is now one of the most competitive ﬁelds
for applicants. We train 250 residents in 104 independent
vascular surgery programs. There are 45 integrated (0/5)
residency programs with 97 residents, and six new pro-
grams were approved just this year. Because we have
already identiﬁed 40 new potential sites, we expect the
number of 0/5 programs will double during the next
3 years. The future of vascular surgery is bright!
Leaders in aortic and peripheral vascular care. Few
would argue that the specialty of vascular surgery has a
long and proven record of providing diagnosis, prevention,
and comprehensive high-quality open surgical and endo-
vascular care to vascular patients. We are experts in aortic,
visceral artery, and carotid reconstructions. Vascular sur-
gery maintains a leading position among specialties treating
patients with PAD. In a recent report based on Medicare
claims, vascular surgeons in the last decade exceeded car-
diology and radiology in the number of endovascular
procedures placing stents for PAD in the United States
(Fig 16).46
Leaders in venous disease. In addition to treating
arterial diseases, we also treat patients with a wide spectrum
of disorders of the venous and lymphatic system. An SVS
survey found that 93% of the responding members treated
superﬁcial veins and 86% also treated deep vein problems.47
Evidence is growing on the effectiveness of endovascular
procedures in treating patients with acute deep vein
thrombosis48 and with chronic large vein obstructions.49
Among the increasing number of different specialties
dealing with superﬁcial venous problems, vascular and
general surgeons do most endovenous ablation procedures
for varicose veins and more advanced forms of chronic
venous insufﬁciency.46
Venous diseases have always been close to my heart.
During several decades of venous practice, I was fortunate
enough to treat a large number of patients, and some of
them had most rewardingdif not spectaculardoutcomes
after surgical treatment. Let me share with you very brieﬂy
the cases of three athletes I treated.
I remember well the ﬁrst patient, a 39-year-old inten-
sive care unit nurse, who presented with a 10-year history
of painful leg ulcers that prevented him from practicing
his favorite life-long hobby, long-distance running. His ul-
cers healed after the superﬁcial endoscopic perforator vein
surgery procedure and skin grafting.50 Three years later,
he completed the Alaska Equinox, one of the most difﬁcult
marathons in the United States.
I also recall the pain and problems of another athlete, a
55-year-old man, who had post-thrombotic syndrome andvenous claudication after femoral vein thrombosis. He un-
derwent saphenopopliteal transposition (May-Husni proce-
dure) with excellent clinical outcome51 and was able to
return to run marathons, even super marathons.
Finally, the third patient I would like to mention was
one of the most courageous young women I have ever
operated on. She had severe symptoms of superior vena
cava syndrome and needed open surgical reconstructions.
A few years later, she sent me an article with her smiling
picture as she was crossing the ﬁnish line of the San Fran-
cisco marathon.
The outcomes in these patients were wonderful, but
they were also symbolic to vascular surgery because they
help us answer the question: Why will our specialty succeed
in the Affordable Care Act? Here are my answers:
We will succeed because treatment of vascular patients
is a marathon and not a sprint. We will succeed because we
know about value, quality, safety, service, and costs. Our
tools are more than the basic “hammer and nail”dwe pro-
vide comprehensive care to our patients, care that they
need and, more importantly, they deserve: be it medical,
surgical, or endovascular care. Vascular surgeons do what
is right, for the right reason, at the right time, with the
right tools.
NOW IT IS OUR TIME
So my message to you is, “Now it is our time!” The
services we provide have high value: we save lives, we
save limbs, we prevent stroke, and we heal and prevent ul-
cers, and treat and prevent life-threatening and disabling
venous thromboembolism. We work together with and
help other surgical specialties, and by providing medical
treatment of PAD, we prevent cardiovascular disease. I
know from my own experience that vascular surgeons can
retrain and become “endocompetent.” Our patients need
new, minimally invasive procedures. Our responsibility is
to ensure these procedures are also equally or more effec-
tive than conventional surgical operations.
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formed the dismal natural history of untreated aortic aneu-
rysmal disease, as once reported by Estes52 and by Szilagyi
et al.35 We adopted and, together with an enthusiastic
medical device industry, rapidly developed endovascular
aortic aneurysm repairs. These procedures are less invasive
and equally or more effective than open surgical treat-
ment. Largely due to the increased number of endovascu-
lar repairs, risk-adjusted early mortality after abdominal
aortic aneurysm repairs in the United States between
1999 and 2008 was reduced by 36%, from 4.4% to
2.8%.53 According to the latest National Vital Statistics
Report, mortality from aortic aneurysms and dissections
in the United States decreased by 23%, from 12,986 in
2007 to 10,030 in 2011.54
So we save lives and continue to be leaders in vascular
care.11 We also need to remain a profession with a
continuing quest for excellence.1,55,56 We perfected
comparative effectiveness in vascular care,57 and we have
long known that results mean everything.6 My message
to you is to remind you to keep in mind the platinum
rule of medicine: that we “treat every patient like you’d
want a member of your family treated!”58 Remember
what Dr William J. Mayo once said, “the best interest of
the patient is the only interest to be considered.”59
We are fortunate to belong to the Society for Vascular
Surgery, an organization that cares about its members, ra-
diates excellence, integrity, innovation, and professional-
ism, and advocates so effectively on behalf of vascular
patients and vascular surgeons. A society for the best
vascular care for every patient, every day. It has been an
extraordinary privilege to serve as president of this distin-
guished society, and I thank you for the honor!
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